MT2A and gastric cancer: MT2A simultaneously controls zinc-binding proteins by adding or removing zinc and is transcriptionally inducible by these proteins to target its promoter region, which contains numerous regulatory elements, such as the MRE.434 Therefore, the diminished expression of MZF1/MT2A significantly associates with the malignancy of GC and poor patient outcomes.